Does LEUPROLIDE Cause Urinary retention? 352 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 352 reports of Urinary retention have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.5% of all adverse event reports for LEUPROLIDE.
352
Reports of Urinary retention with LEUPROLIDE
0.5%
of all LEUPROLIDE reports
32
Deaths
181
Hospitalizations
How Dangerous Is Urinary retention From LEUPROLIDE?
Of the 352 reports, 32 (9.1%) resulted in death, 181 (51.4%) required hospitalization, and 4 (1.1%) were considered life-threatening.
Is Urinary retention Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 352 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Urinary retention?
MIRABEGRON (706)
QUETIAPINE (617)
TAMSULOSIN (475)
ADALIMUMAB (452)
MORPHINE (407)
OLANZAPINE (405)
SERTRALINE (380)
PREGABALIN (376)
RISPERIDONE (375)
DULOXETINE (362)
Which LEUPROLIDE Alternatives Have Lower Urinary retention Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM